The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksThruvision Grp Regulatory News (THRU)

Share Price Information for Thruvision Grp (THRU)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 17.50
Bid: 17.00
Ask: 18.00
Change: 0.00 (0.00%)
Spread: 1.00 (5.882%)
Open: 17.50
High: 17.50
Low: 17.50
Prev. Close: 17.50
THRU Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

7 Oct 2021 07:00

RNS Number : 2746O
Thruvision Group PLC
07 October 2021
 

7 October 2021

 

Thruvision Group plc

 

("Thruvision" or the "Group")

 

Trading Update

 

 

Thruvision (AIM:THRU), the leading provider of "safe distance" people-screening technology to the international security market, is pleased to provide an update on trading for the six months ended 30 September 2021.

 

Revenues for the period are expected to be £2.0 million (H1FY21 £4.7 million, H2FY21 £2.0 million). The reduction reflects the fact that last year's comparative included a material order (of £3.0 million) from US Customs and Border Protection (CBP) as described in the results announcement at the time. The period under review did not benefit from a similar order, although, as set out below, we are in ongoing discussions with CBP about potential orders for the second half.

 

Profit Protection

 

Profit Protection revenues grew strongly, by 67%, to £1.0 million (H1FY21 £0.6 million), driven by repeat orders from customers who first purchased from us in the last 12 months. As we explained in our recent Annual Report, we believe that Profit Protection is an important growth market where, in October alone, sales are to expected to exceed those of the entire the first half as our customers prepare for Christmas trading. We are particularly pleased with the high levels of interest in our offering in the strategically important US Profit Protection market where, as well as reducing staff theft, organisations are seeking to improve work place safety after a number of fatal gun-related incidents in distribution centres.

 

US Customs

 

Driven by significant immigration pressure on the southern border with Mexico, our activity levels with CBP are currently very high. Many hundreds of officers are now proficient in using our technology to check immigrants for contraband and weapons at more than 20 locations on the border. With this firm operational base established, we are in discussions about upgrading and expanding the Thruvision fleet more widely across CBP and expect further order flow in the second half as a result.

 

Aviation

 

In Aviation, which has of course been hugely impacted by Covid-19, we have continued to make progress towards US Transportation Security Administration (TSA) accreditation. Such accreditation would enable the use of Thruvision for passenger security screening in US airports. As passenger numbers recover and travel processes permanently adapt to Covid-19, we expect to see renewed interest in our technology given its inherent 'safe distance / no touch' capabilities.

 

International

 

We received no orders in the period from Asia or the Middle East, but have seen continued interest in our technology and we remain optimistic that our business in these regions will recover as more normal trading conditions return.

 

Outlook

 

We continue to manage costs carefully and effectively, with cash of £4.1 million on 30 September 2021 (31 March 2021: £7.3 million). A build-up in our stock levels to support our Profit Protection customers' busy period accounted for £0.9 million of the reduction since the start of the period, with this inventory now allowing us to deliver the strong October sales as described above.

 

Looking forward, we expect to maintain our strong growth rate in Profit Protection across the UK, US and Europe. We also expect to make material progress in expanding our remit with CBP and, in the medium term, win business with further Customs agencies globally. Subject to continued positive progress with TSA, we still see clear longer-term opportunities for our technology in the Aviation sector.

 

 

For further information please contact:

 

Thruvision Group plc +44 (0)1235 425400

Tom Black, Executive Chairman

Colin Evans, Chief Executive

 

Investec Investment Banking (NOMAD & Broker) +44 (0)20 7597 5970

Patrick Robb / James Rudd / Sebastian Lawrence

 

FTI Consulting LLP +44 (0)20 3727 1000

Matt Dixon / Tom Blundell

 

About Thruvision

Addressing the urgent need for "safe distance" people security screening in the COVID era, Thruvision is uniquely capable of detecting metallic and non-metallic items including weapons, explosives and contraband items that are hidden under clothing, at distances between 3 and 10m. Using patented passive terahertz technology, Thruvision completely removes the need for physical "pat-downs" and has been vetted and approved by the US Transportation Security Administration for surface transportation. Operationally deployed in 20 countries around the world, Thruvision is used for aviation security, retail supply chain loss prevention, customs and border control, and public area security. The company has offices near Oxford, and Washington DC.

 

 

www.thruvision.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFLFFDIFLRIIL
Date   Source Headline
26th Apr 20247:00 amRNSYear-end trading update
18th Mar 20247:00 amRNSWalkTHRU completes operational test and evaluation
1st Feb 20247:00 amRNSNext generation product range & software launched
26th Jan 20247:00 amRNSSales Progress Update
22nd Jan 20242:48 pmRNSHolding(s) in Company
10th Jan 202410:39 amRNSAward of Share Options to Executive Director
28th Nov 202311:50 amRNSBlocklisting update
28th Nov 202311:48 amRNSBlocklisting update
20th Nov 20237:00 amRNSInterim Results
13th Nov 20238:51 amRNSUK retail theft to cost £7.9bn in 2023
6th Nov 20234:27 pmRNSNotice of Interim Results
27th Oct 202311:32 amRNSHolding(s) in Company
26th Oct 20232:34 pmRNSHolding(s) in Company
26th Oct 20232:23 pmRNSHolding(s) in Company
25th Oct 202312:04 pmRNSHolding(s) in Company
24th Oct 20237:00 amRNSResult of placing
23rd Oct 20234:35 pmRNSLaunch of placing
2nd Oct 20237:00 amRNSHalf year trading update
21st Sep 202311:12 amRNSResult of Annual General Meeting
22nd Aug 202311:56 amRNSAward of Share Options to Executive Directors
21st Jul 20237:00 amRNSResults for the year ended 31 March 2023
13th Jul 20235:09 pmRNSNotice of Results
7th Jun 20237:00 amRNSBlocklisting update
7th Jun 20237:00 amRNSBlocklisting update
21st Apr 20237:00 amRNSYear end trading update
3rd Feb 20237:00 amRNSSharesave option grant to Executive Director
12th Jan 202310:24 amRNSChange of Auditor
21st Dec 20227:00 amRNSDirector Share Dealing
19th Dec 20227:00 amRNSInterim Results
15th Dec 20227:00 amRNSCORRECTION - Blocklisting Update
13th Dec 20227:00 amRNSBlocklisting Update
13th Dec 20227:00 amRNSBlocklisting Update
30th Nov 20227:00 amRNSNotice of Results
9th Nov 20227:00 amRNSAward of Share Options to Executive Directors
8th Nov 20222:50 pmRNSHolding(s) in Company
26th Oct 202211:50 amRNSResult of AGM
12th Oct 20227:00 amRNSH1 Trading Update
3rd Oct 20227:00 amRNSCBP Framework Agreement and Contract Award
30th Sep 20227:00 amRNSResults for the Year ended 31 March 2022
22nd Sep 20223:00 pmRNSContract Award, Trading Update, Notice of Results
16th Jun 20227:00 amRNSAppointment of Chief Financial Officer
15th Jun 20228:31 amRNSHolding(s) in Company
8th Jun 20223:32 pmRNSBlocklisting update
8th Jun 20223:30 pmRNSBlocklisting update
6th May 202212:12 pmRNSDirector Share Dealing-correction & further trade
20th Apr 20227:00 amRNSDirector Share Dealing
4th Apr 20227:00 amRNSYear End Trading Update and Board Changes
1st Apr 20227:01 amRNSBlocklisting update
1st Apr 20227:00 amRNSBlocklisting update
9th Mar 202212:40 pmRNSDirector Share Dealing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.